TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has issued an update.
Sinco Pharmaceuticals Holdings Ltd. has announced the composition of its board of directors and their roles within the company. The board consists of executive, non-executive, and independent non-executive directors, with various members assigned to committees such as Audit, Remuneration, Nomination, and Internal Control and Corporate Governance. This announcement reflects the company’s commitment to robust governance and strategic oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:6833) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products, serving a diverse market with a range of healthcare solutions.
Average Trading Volume: 280,181
Technical Sentiment Signal: Buy
Current Market Cap: HK$496M
See more data about 6833 stock on TipRanks’ Stock Analysis page.